Back to top

VKTX Maintains Buy Rating -- Price Target Raised to $114.00 by Canaccord Genuity

VKTX Maintains Buy Rating -- Price Target Raised to $114.00 by Canaccord Genuity

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Viking Therapeutics, Inc. (VKTX)